Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case–Control Study in Mexican Patients
Genes · 2023
DOI: 10.3390/genes14122130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Adriana Aguayo-Arelis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Psicología Aplicada, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Ameca 46600, Mexico. Hauptthemen laut MEDLINE: Multiple Sclerosis, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Latin American Committee for Treatment and Research in Multiple Sclerosis, University of Guadalajara, LACTRIMS.
Abstract (Originalsprache)
Cognition is a set of brain processes that allow the individual to interact with their environment. Multiple sclerosis (MS) is a chronic inflammatory disease that affects the cerebral white matter of the brain cortex and spinal cord, leading to cognitive impairment (CI) in 40–60% of the patients. Many studies have determined that CI is linked to genetic risk factors. We aimed to evaluate the association between BDNF gene rs6265 polymorphism and cognitive impairment in Mexican patients with MS by performing a case–control study. Mestizo-Mexican patients diagnosed with MS based on McDonald’s criteria were enrolled. Cases were MS patients with CI (n = 31) while controls were MS patients without CI (n = 31). To measure cognitive functioning in MS patients, a neuropsychological screening battery for MS (NSB-MS) was used. Genotyping of the rs6265 gene variant was performed using quantitative real-time PCR (qPCR) with TaqMan probes. The results showed no statistically significant differences in sociodemographic and disease variables between case and control groups. qPCR analysis showed that there were 68% Val/Val wild-type homozygotes, 29% Val/Met polymorphic heterozygotes, and 3% Met/Met polymorphic homozygotes. The presence of BDNF gene rs6265 polymorphism showed an increased probability (3.6 times) of global cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Psicología Aplicada, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Ameca 46600, Mexico.
- Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Ameca 46600, Mexico.
ORCID-Profile: Brenda Viridiana Rabago-Barajas
Förderung
- Latin American Committee for Treatment and Research in Multiple Sclerosis
- University of Guadalajara
- LACTRIMS
- Incorporation and Permanence of Postgraduate Program from the Universidad de Guadalajara
Zitieren
APA
Aguayo-Arelis, A., Rabago-Barajas, B. V., Saldaña-Cruz, A. M., & Macías-Islas, M. Á. (2023). Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case–Control Study in Mexican Patients. Genes. https://doi.org/10.3390/genes14122130
Vancouver
Aguayo-Arelis A, Rabago-Barajas BV, Saldaña-Cruz AM, Macías-Islas MÁ. Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case–Control Study in Mexican Patients. Genes. 2023. doi:10.3390/genes14122130
BibTeX
@article{AguayoArelis2023,
author = {Aguayo-Arelis, Adriana and Rabago-Barajas, Brenda Viridiana and Saldaña-Cruz, Ana Miriam and Macías-Islas, Miguel Ángel},
title = {Association of the BDNF rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case–Control Study in Mexican Patients},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14122130}
}
EUVIMED